clinical trial design

  • Tufts University Boston

    Clinical trial feasibility – it’s a standard part of recruitment planning and essential for predicting enrollment success. Yet so often it’s easy to get wrong, putting timelines and budget at risk. And whether that’s because there’s too great a focus on quantitative factors – such as volume of patients or number of competing studies – it’s clear that study sponsors and sites can benefit from an

  • Tufts University Boston

    Sexual and gender minority (SGM) is an umbrella term that encompasses lesbian, gay, bisexual, and transgender populations as well as those whose sexual orientation, gender identity and expressions, or reproductive development varies from traditional, societal, cultural, or physiologic norms. Research with SGM populations is lacking, but is desperately needed to help understand and improve their

  • Tufts University Boston

    Why is it important to include older adults in research, and how can it improve your study? NIH’s new policy on Inclusion Across the Lifespan went into effect January 2019 requiring the inclusion of people of all ages in research studies. In this course, you will find out the scientific and ethical reasoning behind this policy change, especially as it pertains to the inclusion of older adults in

  • Tufts University Boston

    Need a larger sample size for your clinical trial? Interested in increasing research participation from children with diverse backgrounds? Want to prepare to conduct regulatory science in an ever-changing networked environment? The content in this course was presented on April 18, 2018 in Washington, D.C., as part of the Association for Clinical and Translational Science (ACTS) 2018 meeting.

  • Tufts University Boston

    What is a pragmatic trial, and what methodological challenges should you consider?

  • National COVID Cohort Collaborative (N3C)
    Center for Data to Health

    Melissa Haendel, PhD, FAMIA, Dan Housman, BSc, Hemalkumar Mehta, PhD, Charisse Madlock-Brown, PhD, MLS & Anita Walden, MA Researchers planning COVID-19 trials with the Trial Innovation Network (TIN) can leverage the N3C to inform their research hypotheses. N3C focuses on aligning its infrastructure so that it can generate efficient and minimally biased results. Part of that infrastructure includes

  • Course image saying C/T Research Academy and dates of course in white text over a blue background with light blue geometric shapes.
    Harvard Medical School

    Training program: C/T Research Academy Session Dates: July 2021 – May 2023 Application Deadline: January 29, 2021 The goal of the C/T Research Academy is to support, nurture, and grow the next generation of c/t investigators at Harvard Medical School. The program offers advanced training to early-career c/t researchers, with a focus on the core knowledge necessary to achieve success in c/t

  • University Of Southern California

    In this session, we explore the importance of ensuring biomedical study samples and data that are inclusive of a wide range of participants. We also examine the challenges associated with recruiting diverse study participants. Finally, we explore the importance of ensuring cultural competence when interacting with participants from historically marginalized groups (e.g., race/ethnicity, religion

  • A team of Penn State researchers developed a first-of-its-kind clinical trial to test the use of exercise as a treatment for patients with a severe form of nonalcoholic fatty liver disease. Nonalcoholic fatty liver disease is the leading cause of chronic liver disease in the United States. People with this disease have an extra fat build up in their liver cells not caused by drinking alcohol. It
  • Using the REDCap software platform, a team of researchers led from Vanderbilt University Medical Center have developed a new framework for electronic consent in clinical trials that’s designed to address both issues of transparency, efficiency and compliance while also improving participant recruitment and retention of under-represented minority groups. According to a preproof article for the

  • Harvard Medical School
    9-week hybrid (in-person/online) course on the design & implementation of clinical trials. Clinical Trial Design (CTD) is an opportunity for new clinical investigators, who have an idea for development of a clinical trial, to participate in an intensive nine-week course. Participants will learn the fundamentals of clinical trial design, including instructions on how to design a protocol
  • University Of Wisconsin-Madison
    Marshfield Clinical Research Institute
    These training modules consist of recorded slide presentations prepared by David DeMets, PhD, Professor of Biostatistics and Medical Informatics. They provide an overview of the fundamentals of clinical trials and can be viewed at your own pace. Note: You will need to have the Adobe Flash Player installed to view these modules. CLINICAL TRIALS BASICS This training module provides a brief